BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27211104)

  • 1. Interferon-γ and Tumor Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype.
    Jin P; Zhao Y; Liu H; Chen J; Ren J; Jin J; Bedognetti D; Liu S; Wang E; Marincola F; Stroncek D
    Sci Rep; 2016 May; 6():26345. PubMed ID: 27211104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells.
    Hemeda H; Jakob M; Ludwig AK; Giebel B; Lang S; Brandau S
    Stem Cells Dev; 2010 May; 19(5):693-706. PubMed ID: 20067407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of IL-10 production by activated B cells via a cell contact-dependent cyclooxygenase-2 pathway upregulated in IFN-γ-treated mesenchymal stem cells.
    Hermankova B; Zajicova A; Javorkova E; Chudickova M; Trosan P; Hajkova M; Krulova M; Holan V
    Immunobiology; 2016 Feb; 221(2):129-36. PubMed ID: 26416211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-α modulates the immunosuppressive effects of MSCs on dendritic cells and T cells.
    Mohammadpour H; Pourfathollah AA; Zarif MN; Tahoori MT
    Int Immunopharmacol; 2015 Oct; 28(2):1009-17. PubMed ID: 26303769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
    Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
    Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing proliferation of murine adipose tissue-derived mesenchymal stem cells by TNF-α plus IFN-γ.
    Mohammadpour H; Pourfathollah AA; Nikougoftar Zarif M; Hashemi SM
    Immunopharmacol Immunotoxicol; 2016; 38(2):68-76. PubMed ID: 26619160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.
    Laranjeira P; Pedrosa M; Pedreiro S; Gomes J; Martinho A; Antunes B; Ribeiro T; Santos F; Trindade H; Paiva A
    Stem Cell Res Ther; 2015 Jan; 6(1):3. PubMed ID: 25559824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells.
    Chinnadurai R; Copland IB; Patel SR; Galipeau J
    J Immunol; 2014 Feb; 192(4):1491-501. PubMed ID: 24403533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
    Zimmermann JA; McDevitt TC
    Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell profiles of human bone marrow-derived mesenchymal stromal cells after IFN-γ and TNF-α licensing.
    Lu S; Qiao X
    Gene; 2021 Mar; 771():145347. PubMed ID: 33333228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synergistic immunomodulatory effects of interferon-gamma and bone marrow mesenchymal stem cells].
    Liang C; Chen SL; Wang M; Zhai WJ; Zhou Z; Pang AM; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):213-6. PubMed ID: 23683418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function.
    Sivanathan KN; Rojas-Canales DM; Hope CM; Krishnan R; Carroll RP; Gronthos S; Grey ST; Coates PT
    Stem Cells; 2015 Sep; 33(9):2850-63. PubMed ID: 26037953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stromal cell plasticity and the tumor microenvironment.
    Bae HJ; Liu S; Jin P; Stroncek D
    Emerg Top Life Sci; 2017 Dec; 1(5):487-492. PubMed ID: 33525796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma and tumor necrosis factor-alpha.
    Robinson CM; Shirey KA; Carlin JM
    J Interferon Cytokine Res; 2003 Aug; 23(8):413-21. PubMed ID: 13678429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.
    English K; Barry FP; Field-Corbett CP; Mahon BP
    Immunol Lett; 2007 Jun; 110(2):91-100. PubMed ID: 17507101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13.
    Marfaing-Koka A; Devergne O; Gorgone G; Portier A; Schall TJ; Galanaud P; Emilie D
    J Immunol; 1995 Feb; 154(4):1870-8. PubMed ID: 7530744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Tumor Necrosis Factor Alpha Dose and Exposure Time on Tumor Necrosis Factor-Induced Gene-6 Activation by Neonatal and Adult Mesenchymal Stromal Cells.
    Hamidian Jahromi S; Li Y; Davies JE
    Stem Cells Dev; 2018 Jan; 27(1):44-54. PubMed ID: 29121823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
    Antonelli A; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Di Domenicantonio A; Ferri C
    J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.